These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
191 related articles for article (PubMed ID: 35040913)
1. Infarct on Brain Imaging, Subsequent Ischemic Stroke, and Clopidogrel-Aspirin Efficacy: A Post Hoc Analysis of a Randomized Clinical Trial. Rostanski SK; Kvernland A; Liberman AL; de Havenon A; Henninger N; Mac Grory B; Kim AS; Easton JD; Johnston SC; Yaghi S JAMA Neurol; 2022 Mar; 79(3):244-250. PubMed ID: 35040913 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of Systolic Blood Pressure, Use of Aspirin and Clopidogrel, and Stroke Recurrence in the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke Trial. de Havenon A; Johnston SC; Easton JD; Kim AS; Sheth KN; Lansberg M; Tirschwell D; Mistry E; Yaghi S JAMA Netw Open; 2021 Jun; 4(6):e2112551. PubMed ID: 34086033 [TBL] [Abstract][Full Text] [Related]
3. Dual Antiplatelet Therapy in Transient Ischemic Attack and Minor Stroke With Different Infarction Patterns: Subgroup Analysis of the CHANCE Randomized Clinical Trial. Jing J; Meng X; Zhao X; Liu L; Wang A; Pan Y; Li H; Wang D; Johnston SC; Wang Y; Wang Y JAMA Neurol; 2018 Jun; 75(6):711-719. PubMed ID: 29582084 [TBL] [Abstract][Full Text] [Related]
4. Outcomes Associated With Clopidogrel-Aspirin Use in Minor Stroke or Transient Ischemic Attack: A Pooled Analysis of Clopidogrel in High-Risk Patients With Acute Non-Disabling Cerebrovascular Events (CHANCE) and Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trials. Pan Y; Elm JJ; Li H; Easton JD; Wang Y; Farrant M; Meng X; Kim AS; Zhao X; Meurer WJ; Liu L; Dietrich D; Wang Y; Johnston SC JAMA Neurol; 2019 Dec; 76(12):1466-1473. PubMed ID: 31424481 [TBL] [Abstract][Full Text] [Related]
5. Risk for Major Hemorrhages in Patients Receiving Clopidogrel and Aspirin Compared With Aspirin Alone After Transient Ischemic Attack or Minor Ischemic Stroke: A Secondary Analysis of the POINT Randomized Clinical Trial. Tillman H; Johnston SC; Farrant M; Barsan W; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Easton JD JAMA Neurol; 2019 Jul; 76(7):774-782. PubMed ID: 31034032 [TBL] [Abstract][Full Text] [Related]
6. Assessment of the End Point Adjudication Process on the Results of the Platelet-Oriented Inhibition in New TIA and Minor Ischemic Stroke (POINT) Trial: A Secondary Analysis. Farrant M; Easton JD; Adelman EE; Cucchiara BL; Barsan WG; Tillman HJ; Elm JJ; Kim AS; Lindblad AS; Palesch YY; Zhao W; Pauls K; Walsh KB; Martí-Fàbregas J; Bernstein RA; Johnston SC JAMA Netw Open; 2019 Sep; 2(9):e1910769. PubMed ID: 31490536 [TBL] [Abstract][Full Text] [Related]
7. Association Between ABCB1 Polymorphisms and Outcomes of Clopidogrel Treatment in Patients With Minor Stroke or Transient Ischemic Attack: Secondary Analysis of a Randomized Clinical Trial. Pan Y; Chen W; Wang Y; Li H; Johnston SC; Simon T; Zhao X; Liu L; Wang D; Meng X; Wang Y; JAMA Neurol; 2019 May; 76(5):552-560. PubMed ID: 30742211 [TBL] [Abstract][Full Text] [Related]
8. Association of CYP2C19 Loss-of-Function Metabolizer Status With Stroke Risk Among Chinese Patients Treated With Ticagrelor-Aspirin vs Clopidogrel-Aspirin: A Prespecified Secondary Analysis of a Randomized Clinical Trial. Xie X; Johnston SC; Wang A; Xu Q; Bath PM; Pan Y; Li H; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Xu A; Jing J; Meng X; Wang Y JAMA Netw Open; 2023 Jun; 6(6):e2317037. PubMed ID: 37279000 [TBL] [Abstract][Full Text] [Related]
9. Clopidogrel and Aspirin Initiated Between 24 to 72 Hours for Mild Ischemic Stroke: A Subgroup Analysis of the INSPIRES Randomized Clinical Trial. Liu Y; Zhao J; Gao Y; Chen W; Johnston SC; Bath PM; Amarenco P; Yan H; Wang X; Yang Y; Wang T; Wang Y; Pan Y; Wang Y JAMA Netw Open; 2024 Sep; 7(9):e2431938. PubMed ID: 39240565 [TBL] [Abstract][Full Text] [Related]
10. Ticagrelor Aspirin vs Clopidogrel Aspirin in Wang A; Meng X; Tian X; Zuo Y; Bath PM; Li H; Xie X; Jing J; Lin J; Wang Y; Zhao X; Liu L; Li Z; Jiang Y; Xu J; Wang F; Chen W; Cao M; Li J; Wang Y Neurology; 2023 Jan; 100(5):e497-e504. PubMed ID: 36535779 [TBL] [Abstract][Full Text] [Related]
11. Time Course for Benefit and Risk With Ticagrelor and Aspirin in Individuals With Acute Ischemic Stroke or Transient Ischemic Attack Who Carry CYP2C19 Loss-of-Function Alleles: A Secondary Analysis of the CHANCE-2 Randomized Clinical Trial. Pan Y; Meng X; Jin A; Johnston SC; Li H; Bath PM; Xie X; Jing J; Lin J; Wang Y; Zhao X; Li Z; Jiang Y; Liu L; Yang H; Cheng J; Wang Z; Wang Y JAMA Neurol; 2022 Aug; 79(8):739-745. PubMed ID: 35727586 [TBL] [Abstract][Full Text] [Related]
12. Time Course for Benefit and Risk of Clopidogrel and Aspirin After Acute Transient Ischemic Attack and Minor Ischemic Stroke. Johnston SC; Elm JJ; Easton JD; Farrant M; Barsan WG; Kim AS; Lindblad AS; Palesch YY; Zurita KG; Albers GW; Cucchiara BL; Kleindorfer DO; Lutsep HL; Pearson C; Sethi P; Vora N; Circulation; 2019 Aug; 140(8):658-664. PubMed ID: 31238700 [TBL] [Abstract][Full Text] [Related]
13. Stroke Recurrence and Antiplatelets in Posterior Versus Anterior Circulation Minor Stroke or Transient Ischemic Attack. Liu H; Jing J; Wang A; Xu Q; Meng X; Li H; Li Z; Wang Y Stroke; 2023 Apr; 54(4):964-972. PubMed ID: 36789773 [TBL] [Abstract][Full Text] [Related]
14. Clopidogrel with indobufen or aspirin in minor ischemic stroke or high-risk transient ischemic attack: a randomized controlled clinical study. Liu X; Lv X; Peng Y; Wang J; Lei J; Tang C; Luo S; Mai W; Cai Y; Fan Q; Liu C; Zhang L BMC Neurol; 2024 Mar; 24(1):81. PubMed ID: 38429754 [TBL] [Abstract][Full Text] [Related]
15. Comparison of Ticagrelor vs Clopidogrel in Addition to Aspirin in Patients With Minor Ischemic Stroke and Transient Ischemic Attack: A Network Meta-analysis. Lun R; Dhaliwal S; Zitikyte G; Roy DC; Hutton B; Dowlatshahi D JAMA Neurol; 2022 Feb; 79(2):141-148. PubMed ID: 34870698 [TBL] [Abstract][Full Text] [Related]
16. Disability After Minor Stroke and Transient Ischemic Attack in the POINT Trial. Cucchiara B; Elm J; Easton JD; Coutts SB; Willey JZ; Biros MH; Ross MA; Johnston SC Stroke; 2020 Mar; 51(3):792-799. PubMed ID: 32078486 [TBL] [Abstract][Full Text] [Related]
17. Association Between CYP2C19 Loss-of-Function Allele Status and Efficacy of Clopidogrel for Risk Reduction Among Patients With Minor Stroke or Transient Ischemic Attack. Wang Y; Zhao X; Lin J; Li H; Johnston SC; Lin Y; Pan Y; Liu L; Wang D; Wang C; Meng X; Xu J; Wang Y; JAMA; 2016 Jul; 316(1):70-8. PubMed ID: 27348249 [TBL] [Abstract][Full Text] [Related]
18. Association of Black Race With Early Recurrence After Minor Ischemic Stroke or Transient Ischemic Attack: Secondary Analysis of the POINT Randomized Clinical Trial. Kamel H; Zhang C; Kleindorfer DO; Levitan EB; Howard VJ; Howard G; Soliman EZ; Johnston SC JAMA Neurol; 2020 May; 77(5):601-605. PubMed ID: 32091536 [TBL] [Abstract][Full Text] [Related]
19. Triple versus guideline antiplatelet therapy to prevent recurrence after acute ischaemic stroke or transient ischaemic attack: the TARDIS RCT. Bath PM; Woodhouse LJ; Appleton JP; Beridze M; Christensen H; Dineen RA; Flaherty K; Duley L; England TJ; Havard D; Heptinstall S; James M; Kasonde C; Krishnan K; Markus HS; Montgomery AA; Pocock S; Randall M; Ranta A; Robinson TG; Scutt P; Venables GS; Sprigg N Health Technol Assess; 2018 Aug; 22(48):1-76. PubMed ID: 30179153 [TBL] [Abstract][Full Text] [Related]
20. Aminotransferase Level and the Effects of Dual Antiplatelet in Minor Stroke or Transient Ischemic Attack: A post hoc Analysis of a Randomized Control Trial. Suo Y; Pan Y; Chen W; Jing J; Yan H; Li H; Liu L; Zhao X; Wang Y; Meng X; Wang Y; Cerebrovasc Dis; 2023; 52(4):442-450. PubMed ID: 36502795 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]